Cyberounds Logo
August 05, 2020 | LOGIN | REGISTER | HELP | 


email a friend print Bookmark and Share
GI Manifestations of Covid-19
Max Schmulson, M.D., R.F.F.

Dr. Max Schmulson is Professor of Medicine at the Faculty of Medicine, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.

Within the past 12 months, Dr. Schmulson has been on the Speakers Bureau for Takeda Mexico, received research support from Takeda Mexico and Alfa Sigma Mexico, and been a consultant for Gemelli Biotech.

Albert Einstein College of Medicine – Montefiore Medical Center CCPD staff and interMDnet staff have nothing to disclose relevant to this activity.



Release Date: 07/08/2020
Termination Date: 07/07/2023
Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • List the diverse GI manifestations of COVID-19 illness.
  • Describe the underlying mechanisms of GI symptoms in patients with COVID-19.
  • Anticipate the possibility of diagnosing of SARS-CoV-2 infection in stools and monitor potential preventive measures for fecal-oral transmission.

 
The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity